A detailed history of Foundry Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Foundry Partners, LLC holds 139,682 shares of MRK stock, worth $13.6 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
139,682
Previous 140,380 0.5%
Holding current value
$13.6 Million
Previous $17.4 Million 8.73%
% of portfolio
0.81%
Previous 0.95%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$111.15 - $128.97 $77,582 - $90,021
-698 Reduced 0.5%
139,682 $15.9 Million
Q2 2024

Aug 05, 2024

BUY
$123.8 - $132.96 $1.52 Million - $1.64 Million
12,304 Added 9.61%
140,380 $17.4 Million
Q1 2024

May 08, 2024

BUY
$113.24 - $131.95 $458,735 - $534,529
4,051 Added 3.27%
128,076 $16.9 Million
Q4 2023

Feb 01, 2024

SELL
$100.18 - $109.02 $1.54 Million - $1.68 Million
-15,365 Reduced 11.02%
124,025 $13.5 Million
Q3 2023

Nov 09, 2023

SELL
$102.95 - $114.33 $4.76 Million - $5.29 Million
-46,268 Reduced 24.92%
139,390 $14.4 Million
Q2 2023

Jul 12, 2023

SELL
$108.61 - $118.38 $81,240 - $88,548
-748 Reduced 0.4%
185,658 $21.4 Million
Q1 2023

May 03, 2023

SELL
$102.94 - $114.86 $12.6 Million - $14 Million
-122,085 Reduced 39.57%
186,406 $19.8 Million
Q4 2022

Jan 30, 2023

SELL
$87.44 - $112.11 $7.73 Million - $9.91 Million
-88,384 Reduced 22.27%
308,491 $34.2 Million
Q3 2022

Oct 21, 2022

SELL
$84.53 - $94.96 $4.15 Million - $4.66 Million
-49,090 Reduced 11.01%
396,875 $34.2 Million
Q2 2022

Jul 28, 2022

BUY
$83.49 - $94.64 $4.68 Million - $5.31 Million
56,070 Added 14.38%
445,965 $40.7 Million
Q1 2022

Apr 14, 2022

BUY
$73.51 - $82.4 $28.7 Million - $32.1 Million
389,895 New
389,895 $32 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Foundry Partners, LLC Portfolio

Follow Foundry Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foundry Partners, LLC with notifications on news.